期刊文献+

急性冠脉综合征患者经皮冠脉介入术后Lp-PLA2、hs-CRP、NT-proBNP水平对预后的评估价值 被引量:5

Evaluation Value of Lp-PLA2, Hs-CRP and NT-proBNP Levels in the Prognosis of ACS Patients after PCI
原文传递
导出
摘要 目的探讨急性冠脉综合征(ACS)患者经皮冠脉介入术(PCI)后脂蛋白相关磷脂酶A2(Lp-PLA2)、超敏C反应蛋白(hs-CRP)、N末端B型钠尿肽原(NT-proBNP)对预后的评估价值。方法选取2017年3月至2019年10月接受PCI治疗的ACS患者187例,术后进行6个月随访,根据是否发生主要不良心血管事件(MACE)分为无MACE组(126例)和MACE组(61例)。分别于介入手术前和介入手术后3d,检测两组患者Lp-PLA2、hs-CRP、NT-proBNP,以及左心室射血分数(LVEF)、心脏每搏量(SV)、心脏指数(CI)。采用多因素Logistic逐步回归分析MACE的危险因素,采用ROC曲线下面积(AUC)评价不同指标对MACE发生的诊断效能。结果两组患者介入治疗后3d的Lp-PLA2、hs-CRP、NT-proBNP水平与介入治疗前比较明显下降(P<0.05),MACE组介入治疗后3d的Lp-PLA2、hs-CRP、NT-proBNP水平高于无MACE组(P<0.05)。两组患者在介入治疗后3d的LVEF、SV、CI与介入治疗前比较明显增高(P<0.05),MACE组介入治疗后3d的LVEF、SV、CI水平低于无MACE组(P<0.05)。Lp-PLA2、hs-CRP、NT-proBNP为MACE发生的独立危险因素(P<0.05),LVEF为MACE发生的独立保护因素(P<0.05)。Lp-PLA2、hs-CRP、NT-proBNP预测MACE的AUC均明显高于LVEF(Z=6.035、5.061、4.983,P<0.001)。结论Lp-PLA2、hs-CRP、NT-proBNP与MACE的发生独立相关,有可能成为ACS患者PCI术后预后的良好监测指标。 Objective To investigate the evaluation value of lipoprotein-associated phospholipase A2(Lp-PLA2),hypersensitive C-reactive protein(hs-CRP)and N end of B-type natriuretic peptide original(NT-proBNP)levels in the prognosis of acute coronary syndrome(ACS)patients after percutaneous coronary intervention(PCI).Methods A total of 187 ACS patients admitted to our hospital from March 2017 to October 2019 who received PCI were selected.The patients were followed up for 6 months after the operation.According to the occurrence of major adverse cardiovascular events(MACE),126 patients in non-MACE group and 61 patients in MACE group were divided.Lp-PLA2,hsCRP,NT-proBNP,left ventricular ejection fraction(LVEF),stroke volume(SV),and cardiac index(CI)were measured before interventional therapy and on the 3 rd day after interventional therapy,respectively.Multivariate Logistic stepwise regression was used to analyze the risk factors of MACE,and the area under ROC curve(AUC)was used to evaluate the diagnostic efficacy of different indicators for MACE.Results Lp-PLA2,hs-CRP and NT-proBNP levels after interventional therapy in the two groups were significantly decreased(P<0.05),and Lp-PLA2,hs-CRP and NT-proBNP levels after interventional therapy in the MACE group were higher than those in the non-MACE group(P<0.05).LVEF,SV and CI on the 3 rd day after interventional therapy in the two groups were significantly higher than those before interventional therapy(P<0.05),and LVEF,SV and CI on the 3 rd day after interventional therapy in the MACE group were lower than those in the non-MACE group(P<0.05).Lp-PLA2,hs-CRP and NT-proBNP were the independent risk factors for MACE(P<0.05),and LVEF was the independent protective factor for MACE(P<0.05).AUC of Lp-PLA2,hs-CRP and NT-proBNP for predicting MACE occurrence was significantly higher than that of LVEF(Z=6.035,5.061,4.983,P<0.001).Conclusion Lp-PLA2,hs-CRP and NT-proBNP are independently correlated with the occurrence of MACE,and may be good indicators for monitoring the prognosis of ACS patients after PCI.
作者 王宏伟 李令娟 刘冬 王卫娟 孙美娜 WANG Hong-weil;LI Ling-juan;LIU Dong;WANG Wei-juan;SUN Mei-na(Interventin Departmen,Fourh People's Hospial of Lang/Affiliated Hospial of Chende Medical College,Langfang 065700,Hebei,China;Deparment of Criovacalar Medicine,Fourh People's Hospial of Lang/Affiliated Hospial of Chende Medical College,Langfang 065700,Hebei,China)
出处 《中国分子心脏病学杂志》 CAS 2021年第5期4191-4194,共4页 Molecular Cardiology of China
基金 廊坊市科学技术研究与发展计划(2020013102)。
关键词 急性冠脉综合征 经皮冠脉介入术 主要不良心血管事件 脂蛋白相关磷脂酶A2 超敏C反应蛋白 N末端B型钠尿肽原 Acute coronary syndrome Percutaneous coronary intervention Major adverse cardiovascular events Lipoprotein-associated phospholipase A2 Hypersensitive C-reactive protein N end of B-type natriuretic peptide original
  • 相关文献

参考文献10

二级参考文献135

  • 1刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 2王小艳.急性冠脉综合征后6个月死亡和心肌梗死的预测:前瞻性的多国观察性研究(GRACE)[J].中国处方药,2006(11):25-26. 被引量:138
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 4沈潞华,高润霖,戚文航,等.慢性稳定型心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,55(2):198.
  • 5Goldstein LB,Bushnell CD,Adams RJ,et al.Guidelines for the pri-mary prevention of stroke:A guideline for healthcare professionalsfrom the American heart association/American stroke association[J].Stroke,2011,42(2):517-584.
  • 6Gensini GG.A more meaningful scoring system for determining theseverity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
  • 7Kosuge M,Ebina T,Hibi K,et al.Value of serial C-reactive pro-tein measurements in non ST-segment elevation acute coronarysyndromes[J].Clin Cardiol,2008,31(9):437-442.
  • 8Eto K,Ochiai M,Isshiki T,et al.Platelet aggregability under shearis enhanced in patients with unstable angina pectoris who developedacute myocardial infarction[J].Jpn Circ J,2001,65(4):279-282.
  • 9HAKKINEN T, LUOMA J S, HILTUNEN M O, et al. Lipoprotein-associated phospholipase A(2), plate- let-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic le- sions[J]. Arterioscler Thromb Vasc Biol, 1999, 19: 2909--2917.
  • 10FERGUSON J F, HINKLE C C, MEHTA N N, et al. Translational studies of lipoprotein-associated phospholipase A(2) in inflammation and atherosclero- sis[J]. J AmCollCardiol, 2012, 59: 764--772.

共引文献680

同被引文献70

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部